Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > RE:RE:RE:RE:Re: Interesting quote
View:
Post by Hopeforthebest on Feb 03, 2024 5:53pm

RE:RE:RE:RE:Re: Interesting quote

Proph said "Ciao, "We have no idea why the interested parties, advanced discussions, and serious discussions could not lead to a commerical PGX licensing deal. But I bet there are many failures there."

We do have an idea and that is that gagnon has absolutely zero creditability as he has, mislead, made poor business decisions and has run 2 companies into the ground. People do not want to invest their money in a person who the cannot trust to make wise business decisions.

This merger with AEZS is materially a PGX deal. Based on H.C. Wainwrights target prices for AEZS over the last year, and that it is a merger of equals, it arguably values CZO's at a target price between C$1.25-C$2.20 per CZO share. That would obviously take PGX into account. Obviously deals AEZS has under discussion for its diagnostic and that CZO has talked about concerning PGX would be taken into account. Gilles is an insider of both companies and so is very well placed. It is because of gagnon being an insider that we have this proposed merger, no one else wanted to do business with gagnon for the above reason. That is assumng that gagnon even went out to look at any alternatives to this shame merger. That is highly doubted as with this merger business continues as usual,sucking money out of the new company so gagnon can his cronies can maintain their lifestyle without every delivering.
 

Carolyn Egbert, Chair of Aeterna: “Ceapro has well-established and growing commercial operations, with potential value-creating pipeline opportunities in large and growing cosmetic and consumer health markets. We believe that the new company will have the capital resources to support this ongoing growth..." 

Carolyn is a nobody and has shown that for the last few year she is just a puppet put in place by gagnon so when the time came she would say the right thing. For this she gets her gold plate freedom 55 pension top up and rides into the sunset.
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities